Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Lifeward Ltd. Director's Dealing 2021

Nov 23, 2021

35158_dirs_2021-11-23_0dda6516-e0d0-4605-99a6-39219ce1eddd.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ReWalk Robotics Ltd. (RWLK)
CIK: 0001607962
Period of Report: 2021-11-22

Reporting Person: Dykan Jeff (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2021-11-22 Ordinary Shares, par value NIS 0.25 per share F 1100 $1.35 Disposed 77373 Indirect

Footnotes

F1: Represents Ordinary Shares sold in the open market on November 22, 2021, in order to satisfy the reporting person's tax withholding obligation in connection with the vesting of certain restricted stock units ("RSUs") previously granted to the reporting person under the ReWalk 2014 Equity Incentive Plan.

F2: The Reporting Person immediately and automatically assigned these Ordinary Shares when they were granted to SCP Vitalife II ("SCP") pursuant to the policies of SCP regarding Shares ownership by its employees, as documented by an Agreement between the Reporting Person and SCP. The Reporting Person is serving on the Board of the Issuer with the permission of SCP.

F3: Market price per share of the Company's Ordinary Shares on the transaction date.

F4: Based on filings made with the SEC, includes 40,707 ordinary shares beneficially owned by SCP Vitalife Partners II, L.P. ("SCP Vitalife Partners II"), a limited partnership organized in the Cayman Islands, 13,596 ordinary shares beneficially owned by SCP Vitalife Partners (Israel) II, L.P. ("SCP Vitalife Partners Israel II"), a limited partnership organized in Israel and 1,571 ordinary shares held by the Israel Innovation Authority (the "IIA"), that Vitalife Partners Overseas, Vitalife Partners Israel and Vitalife Partners DCM have the right to acquire from IIA. The reporting person is therefore deemed to beneficially own 55,874 ordinary shares of the Company